4E Therapeutics

United States
Kingston, Oklahoma, United States

Company profile

4E Therapeutics company profile

4E Therapeutics is developing an innovative therapy for chronic neuropathic pain and is also at the forefront of discovering and developing compounds to treat migraine and acute pain. Neuropathic pain is a serious unmet medical need. They make an effort to regulate the activity of pain-sensing neurons in the peripheral nervous system.

Business identity

Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2019-01-01, Year

Headquarters

Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
2
Last funding
Grant / $5.5M / 2021-11-10
Investors
1
Lead investors
1
Founders
3
Articles
6

Founders and investors

Founders

Craig BensonJoe PriceTed Price

Lead investors

National Institutes of Health

Investors

National Institutes of Health